Myomo Future Growth
Future criteria checks 5/6
Myomo is forecast to grow earnings and revenue by 69.8% and 24% per annum respectively while EPS is expected to grow by 69.9% per annum.
Key information
69.8%
Earnings growth rate
69.9%
EPS growth rate
| Medical Equipment earnings growth | 15.9% |
| Revenue growth rate | 24.0% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 17 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 49 | 5 | N/A | N/A | 1 |
| 12/31/2025 | 41 | -1 | 0 | -1 | 6 |
| 12/31/2024 | 29 | -7 | -9 | -7 | 6 |
| 6/30/2024 | 21 | -9 | -9 | -9 | N/A |
| 3/31/2024 | 20 | -9 | -8 | -8 | N/A |
| 12/31/2023 | 19 | -8 | -6 | -6 | N/A |
| 9/30/2023 | 19 | -8 | -6 | -6 | N/A |
| 6/30/2023 | 17 | -9 | -7 | -7 | N/A |
| 3/31/2023 | 15 | -11 | -10 | -10 | N/A |
| 12/31/2022 | 16 | -11 | -10 | -10 | N/A |
| 9/30/2022 | 16 | -12 | -10 | -10 | N/A |
| 6/30/2022 | 16 | -11 | -9 | -9 | N/A |
| 3/31/2022 | 15 | -11 | -10 | -10 | N/A |
| 12/31/2021 | 14 | -11 | -10 | -10 | N/A |
| 9/30/2021 | 14 | -9 | -9 | -9 | N/A |
| 6/30/2021 | 11 | -10 | -9 | -8 | N/A |
| 3/31/2021 | 9 | -11 | -9 | -9 | N/A |
| 12/31/2020 | 8 | -12 | -9 | -9 | N/A |
| 9/30/2020 | 5 | -13 | -11 | -11 | N/A |
| 6/30/2020 | 4 | -13 | -11 | -11 | N/A |
| 3/31/2020 | 4 | -13 | -10 | -10 | N/A |
| 12/31/2019 | 4 | -12 | -10 | -10 | N/A |
| 9/30/2019 | 3 | -11 | -10 | -10 | N/A |
| 6/30/2019 | 3 | -11 | -10 | -10 | N/A |
| 3/31/2019 | 3 | -11 | -11 | -10 | N/A |
| 12/31/2018 | 2 | -10 | -10 | -10 | N/A |
| 9/30/2018 | 2 | -10 | -9 | -9 | N/A |
| 6/30/2018 | 2 | -8 | -8 | -8 | N/A |
| 3/31/2018 | 2 | -13 | N/A | -7 | N/A |
| 12/31/2017 | 2 | -13 | N/A | -6 | N/A |
| 9/30/2017 | 1 | -12 | N/A | -6 | N/A |
| 6/30/2017 | 1 | -12 | N/A | -5 | N/A |
| 3/31/2017 | 1 | -5 | N/A | -4 | N/A |
| 12/31/2016 | 1 | -4 | N/A | -3 | N/A |
| 9/30/2016 | 1 | -4 | N/A | -3 | N/A |
| 6/30/2016 | 1 | -4 | N/A | -3 | N/A |
| 3/31/2016 | 1 | -4 | N/A | -3 | N/A |
| 12/31/2015 | 1 | -4 | N/A | -3 | N/A |
| 12/31/2014 | 1 | -4 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0M61 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.8%).
Earnings vs Market: 0M61 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 0M61 is expected to become profitable in the next 3 years.
Revenue vs Market: 0M61's revenue (24% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: 0M61's revenue (24% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0M61's Return on Equity is forecast to be high in 3 years time